Erk Activation Is Required for Nrf2 Nuclear Localization during Pyrrolidine Dithiocarbamate Induction of Glutamate Cysteine Ligase Modulatory Gene Expression in HepG2 Cells

Authors: Zipper L.M.; Mulcahy R.T.

Source: Toxicological Sciences, Volume 73, Number 1, May 2003 , pp. 124-134(11)

Publisher: Oxford University Press

Buy & download fulltext article:

OR

Price: $50.43 plus tax (Refund Policy)

Abstract:

Pyrrolidine dithiocarbamate (PDTC) induction of the human glutamate cysteine ligase modulatory (GCLM) gene is dependent on activation of the mitogen-activated protein kinases (MAPKs) extracellular regulated kinase (Erk) and p38, and is not affected by protein kinase C (PKC) or PI3K inhibitors. Nrf2 binding to the electrophile response element (EpRE) located within the GCLM promoter is decreased after MAPK inhibition, suggesting that Nrf2 could be a downstream target of activated MAPK. To evaluate this hypothesis, a series of Nrf2 proteins harboring mutations in conserved consensus MAPK phosphorylation sites were developed and used in multiple functional assays. All mutated Nrf2 proteins tested interacted with the cytoplasmic repressor Keap1 in a manner indistinguishable from wild-type Nrf2. Furthermore, the mutant and wild-type Nrf2 proteins were similarly capable of transactivating an EpRE-containing GCLM/luciferase reporter transgene. Collectively these functional assays suggest that Nrf2 is not likely to be a direct downstream target of activated MAPK in vivo. However, treatment of HepG2 cells with MAPK inhibitors PD98059 and/or SB202190 prior to exposure to PDTC, reduced Nrf2 translocation to the nucleus, suggesting that MAPK-directed phosphorylation is a requirement for nuclear localization during PDTC induction of GCLM gene expression.

Keywords: EpRE; phosphorylation; Erk, p38

Document Type: Original article

Affiliations: 1: Department of Pharmacology, K4/554 Clinical Sciences Center, 600 Highland Avenue, Madison, Wisconsin 53792

Publication date: 2003-05-01

More about this publication?
  • The mission of Toxicological Sciences, the official journal of the Society of Toxicology, is to publish premier peer-reviewed, hypothesis-driven, original research articles in all areas of toxicology. Toxicological Sciences Manuscript Central (ToxSci MC), our online submission system, is located at http://mc.manuscriptcentral.com/toxsci. ToxSci MC facilitates convenient uploading of original and revised manuscripts, as well as online review-ing and intercommunication between authors, editors, and reviewers.
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page